Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends
Background: Despite advancements in lung transplantation (LT), infection remains a major cause of morbidity and mortality following LT. We examined trends in hospitalizations for infection in the first year after LT. Methods: We identified adult LT recipients in the United States (March 1, 2018-Marc...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | JHLT Open |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950133425000266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850040366997176320 |
|---|---|
| author | Shi Nan Feng, BSPH Armaan F. Akbar, BS Alice L. Zhou, MS Andrew Kalra, BS Sean Agbor-Enoh, MD, PhD Christian A. Merlo, MD, MPH Errol L. Bush, MD |
| author_facet | Shi Nan Feng, BSPH Armaan F. Akbar, BS Alice L. Zhou, MS Andrew Kalra, BS Sean Agbor-Enoh, MD, PhD Christian A. Merlo, MD, MPH Errol L. Bush, MD |
| author_sort | Shi Nan Feng, BSPH |
| collection | DOAJ |
| description | Background: Despite advancements in lung transplantation (LT), infection remains a major cause of morbidity and mortality following LT. We examined trends in hospitalizations for infection in the first year after LT. Methods: We identified adult LT recipients in the United States (March 1, 2018-March 9, 2023) using the Organ Procurement and Transplantation Network database. We categorized transplants into 3 eras to account for the Composite Allocation Score allocation policy change and coronavirus disease 2019: March 2018 to March 2020, March 2020 to March 2022, and March 2022 to March 9, 2023. One-year post-LT survival was compared using Kaplan-Meier survival analysis and Cox proportional hazards regression. Hospitalizations for infection were compared using multivariable logistic regression, adjusted for era and donor and recipient characteristics. Results: Of 12,388 LT recipients (median age = 62, male = 61.2%), hospitalization for infection in the first-year post transplant was 5.2% for patients transplanted from March 2018 to March 2020 (N = 5,031), 7.6% from March 2020 to March 2022 (N = 4,659), and 13.2% post-March 2022 (N = 3,640) (p < 0.001). Compared to March 2018 to March 2020, patients transplanted from March 2020 to March 2022 (adjusted aoods ratio [aOR] = 1.50, 95% confidence interval [CI] = 1.26-1.79) and post-March 2022 (aOR = 2.89, 95% CI = 2.29-3.65) were more likely to be hospitalized for an infection. After adjustment, we found no significant difference in risk of death following LT for recipients transplanted between March 2020 and March 2022 (aHR = 1.09, 95% CI = 0.96-1.23, p = 0.175) compared to March 2018 and March 2020. Post-March 2022 risk of death was elevated (aHR = 1.21, 95% CI = 1.04, 1.40, p = 0.014). Conclusions: Odds of hospitalization for infection in the first year after LT performed between March 2020 and March 2022 and post-March 2022 were 1.50 and 2.89 times as high, respectively, as LT performed between March 2018 and March 2020. IRB NUMBERS: IRB00352819 |
| format | Article |
| id | doaj-art-e932430153b34f5ca03430f2f30d38be |
| institution | DOAJ |
| issn | 2950-1334 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JHLT Open |
| spelling | doaj-art-e932430153b34f5ca03430f2f30d38be2025-08-20T02:56:06ZengElsevierJHLT Open2950-13342025-05-01810023110.1016/j.jhlto.2025.100231Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trendsShi Nan Feng, BSPH0Armaan F. Akbar, BS1Alice L. Zhou, MS2Andrew Kalra, BS3Sean Agbor-Enoh, MD, PhD4Christian A. Merlo, MD, MPH5Errol L. Bush, MD6Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PennsylvaniaDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; Corresponding author: Errol L. Bush, MD, Advanced Lung Disease and Lung Transplant Program, Johns Hopkins Medical Institutions, Blalock 240, 600 North Wolfe St, Baltimore, MD 21287. Telephone: 410-614-3891. Fax: 410-614-2079.Background: Despite advancements in lung transplantation (LT), infection remains a major cause of morbidity and mortality following LT. We examined trends in hospitalizations for infection in the first year after LT. Methods: We identified adult LT recipients in the United States (March 1, 2018-March 9, 2023) using the Organ Procurement and Transplantation Network database. We categorized transplants into 3 eras to account for the Composite Allocation Score allocation policy change and coronavirus disease 2019: March 2018 to March 2020, March 2020 to March 2022, and March 2022 to March 9, 2023. One-year post-LT survival was compared using Kaplan-Meier survival analysis and Cox proportional hazards regression. Hospitalizations for infection were compared using multivariable logistic regression, adjusted for era and donor and recipient characteristics. Results: Of 12,388 LT recipients (median age = 62, male = 61.2%), hospitalization for infection in the first-year post transplant was 5.2% for patients transplanted from March 2018 to March 2020 (N = 5,031), 7.6% from March 2020 to March 2022 (N = 4,659), and 13.2% post-March 2022 (N = 3,640) (p < 0.001). Compared to March 2018 to March 2020, patients transplanted from March 2020 to March 2022 (adjusted aoods ratio [aOR] = 1.50, 95% confidence interval [CI] = 1.26-1.79) and post-March 2022 (aOR = 2.89, 95% CI = 2.29-3.65) were more likely to be hospitalized for an infection. After adjustment, we found no significant difference in risk of death following LT for recipients transplanted between March 2020 and March 2022 (aHR = 1.09, 95% CI = 0.96-1.23, p = 0.175) compared to March 2018 and March 2020. Post-March 2022 risk of death was elevated (aHR = 1.21, 95% CI = 1.04, 1.40, p = 0.014). Conclusions: Odds of hospitalization for infection in the first year after LT performed between March 2020 and March 2022 and post-March 2022 were 1.50 and 2.89 times as high, respectively, as LT performed between March 2018 and March 2020. IRB NUMBERS: IRB00352819http://www.sciencedirect.com/science/article/pii/S2950133425000266lung transplanthospitalizationinfectiontrendssurvival |
| spellingShingle | Shi Nan Feng, BSPH Armaan F. Akbar, BS Alice L. Zhou, MS Andrew Kalra, BS Sean Agbor-Enoh, MD, PhD Christian A. Merlo, MD, MPH Errol L. Bush, MD Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends JHLT Open lung transplant hospitalization infection trends survival |
| title | Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends |
| title_full | Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends |
| title_fullStr | Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends |
| title_full_unstemmed | Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends |
| title_short | Increasing risk of postlung transplant hospitalizations for infection: An analysis of recent trends |
| title_sort | increasing risk of postlung transplant hospitalizations for infection an analysis of recent trends |
| topic | lung transplant hospitalization infection trends survival |
| url | http://www.sciencedirect.com/science/article/pii/S2950133425000266 |
| work_keys_str_mv | AT shinanfengbsph increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT armaanfakbarbs increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT alicelzhoums increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT andrewkalrabs increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT seanagborenohmdphd increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT christianamerlomdmph increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends AT errollbushmd increasingriskofpostlungtransplanthospitalizationsforinfectionananalysisofrecenttrends |